Published in Drug Law Weekly, November 8th, 2011
"CE Mark approval is an important confirmation of the substantial benefits that patients receive from our HGNS...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.